Skip to main content
logo
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.220
+0.010 (0.83%)
At close: Aug 21, 2026, 4:00 PM EDT
1.230
+0.010 (0.82%)
After-hours: Aug 21, 2026, 7:39 PM EDT

Spero Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
7.388.57-68.5722.81-46.42-89.76
Depreciation & Amortization
--00.370.870.65
Asset Writedown & Restructuring Costs
0.590.59-5.310.64-
Loss (Gain) From Sale of Investments
----0.010.25
Stock-Based Compensation
3.994.337.797.939.129.43
Other Operating Activities
0.951.051.040.975.962.22
Change in Accounts Receivable
24.4524.0346.35-95.741.553.05
Change in Accounts Payable
-0.63-6.615.930.76-0.48-0.05
Change in Unearned Revenue
-18.01-34.66-26.6329.0121.8910.64
Change in Income Taxes
-0.21-0.210.39-0.78
Change in Other Net Operating Assets
0.85-10.1210.84-4.79-0.87-1.56
Operating Cash Flow
19.58-12.62-23.44-33-7.73-64.35
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sale of Property, Plant & Equipment
-----0.04
Investment in Securities
----33.817.63
Investing Cash Flow
----33.817.67

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
---0.2224.9336.82
Other Financing Activities
-----54.4947.23
Financing Cash Flow
---0.22-29.5584.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
19.58-12.62-23.44-32.77-3.4827.38

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
19.58-12.62-23.44-33-7.73-64.35
Free Cash Flow Growth
------
Free Cash Flow Margin
41.66%-18.90%-48.86%-31.79%-14.45%-352.47%
Free Cash Flow Per Share
0.33-0.21-0.43-0.62-0.21-2.08
Levered Free Cash Flow
28.85-4.25-25.13-9.9-1.08-41.44
Unlevered Free Cash Flow
28.85-4.25-25.13-9.90.55-40.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
---2.21--
Change in Working Capital
6.67-27.1636.28-70.3822.0912.86
SEC Filings: 10-K · 10-Q